Collectively, these data indicate that GAS has minimal impact upon human neutrophil CD11b and CD66b, but increases the loss of CD16 and CD31 expression, which may impact opsonisation of GAS and subsequent efferocytosis of neutrophils by macrophages, during infection. The gene discussed is PECAM1; the disease is infection.